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Abstract: Although photobiomodulation (PBM) has proven promising to treat wounds, the lack
of univocal guidelines and of a thorough understanding of light–tissue interactions hampers its
mainstream adoption for wound healing promotion. This study compared murine and human
fibroblast responses to PBM by red (635 ± 5 nm), near-infrared (NIR, 808 ± 1 nm), and violet-blue
(405 ± 5 nm) light (0.4 J/cm2 energy density, 13 mW/cm2 power density). Cell viability was not
altered by PBM treatments. Light and confocal laser scanning microscopy and biochemical analyses
showed, in red PBM irradiated cells: F-actin assembly reduction, up-regulated expression of Ki67
proliferation marker and of vinculin in focal adhesions, type-1 collagen down-regulation, matrix
metalloproteinase-2 and metalloproteinase-9 expression/functionality increase concomitant to their
inhibitors (TIMP-1 and TIMP-2) decrease. Violet-blue and even more NIR PBM stimulated collagen
expression/deposition and, likely, cell differentiation towards (proto)myofibroblast phenotype. Indeed,
these cells exhibited a higher polygonal surface area, stress fiber-like structures, increased vinculin- and
phospho-focal adhesion kinase-rich clusters and α-smooth muscle actin. This study may provide the
experimental groundwork to support red, NIR, and violet-blue PBM as potential options to promote
proliferative and matrix remodeling/maturation phases of wound healing, targeting fibroblasts, and to
suggest the use of combined PBM treatments in the wound management setting.
Keywords: cytoskeleton; confocal immunofluorescence; diode laser; fibroblast; light emitting diode
(LED); low level laser therapy (LLLT); matrix metalloproteinases; morphology; myofibroblast; wound
1. Introduction
Photobiomodulation (PBM) is a medical technique emerging as a promising therapy to treat
different medical conditions including wounds [1–3]. It represents a painless and non-invasive
approach, consisting in the direct application on the target tissue of light in the visible or near-infrared
(NIR) spectral regions—wavelengths (λ) ranging from 400 to 1100 nm—with a power density less than
100 mW/cm2 and energy density less than 10 J/cm2 at the target, which may be delivered by different
devices such as a laser (coherent light) or LED (light emitting diode, non-coherent light). These light
wavelengths have been demonstrated to penetrate through tissues wherein they act at the cellular
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and molecular levels, mainly absorbed by endogenous mitochondrial photoacceptor/chromophores
and/or activating membrane ion channels. In turn photo-physical and photo-chemical reactions are
induced, which result in the modulation of different cellular processes [1,4–6]. Given these light
features, the light-induced thermal, sound or vibration effects are negligible, and no cell/tissue damages
generally occur. In particular, the ability of PBM to stimulate many key processes necessary for the
effective accomplishment of wound healing such as inflammatory reaction reduction, angiogenesis
promotion, fibroblast proliferation, collagen production and granulation tissue formation has been
demonstrated [3,7–17]. On the other hand, some studies have reported limited effectiveness or
inefficacy or even inhibitory effects of PBM treatments for wound management, thus questioning the
use of PBM in the clinical practice as actual therapeutic option for promotion of wound healing [18–28].
The main reason for these discordant results may certainly depend on the individual clinical conditions,
the heterogeneity of the current clinical trials, the chosen animal experimental model, as well as the
type and severity of the lesion, but most likely on the high degree of complexity inherent to this
technology. Indeed, a large number of devices and parameters, including wavelength, energy density,
power density, pulse structure, irradiation time, and repetition regimen, have been tested [1,29,30].
In addition it must be considered that the occurrence of a biphasic dose-response (whereby low levels
and high levels of light exert stimulatory and inhibitory effects respectively, and there is an optimum
value of PBM energy density) reported for PBM in multiple studies may account for discordant
results [6,31]. Moreover, it is worthy to say that another issue possibly preventing the mainstream
adoption of this therapy is the lack of full comprehension of the interactions between light and tissues
at the cellular and even molecular levels [5,6]. Therefore, studies aimed at the identification of the
most appropriate light wavelengths and the optimum operating parameters of a PBM treatment able
to impact on the functionality of the key cellular elements involved in the wound healing process
and thereby able to really elicit biological effects, improving tissue repair/regeneration, are strongly
encouraged. Such kind of studies may indeed contribute to define univocal standardized guidelines
and to arrange protocols, still lacking, for an effective use of PBM in wound healing, able to elicit
positive clinical outcomes. On these bases, the aim of the present study was to compare the effects
of three different PBM treatments by red (635 nm), NIR (808 nm), and violet-blue (405 nm) light
delivered at a constant energy density of 0.4 J/cm2 and power density of 13 mW/cm2 by diode
lasers (635 and 808 nm) and LED (405 nm), with a single exposure on cultured in vitro fibroblasts,
actually the first cell type migrating and accumulating at the lesion site, responsible for the provisional
extracellular matrix (ECM) deposition and traction/contraction force generation to facilitate wound
closure [32,33]. The rationale of the choice of the tested wavelengths is based on the fact that the
optical spectral range of red and NIR is widely regarded as optical therapeutic window for wound
management wherein the light penetration efficiency in the tissue is maximum. However, also shorter
wavelengths in the range of green or blue have been demonstrated to elicit biological effects and exert
benefits for wound healing [6,10,13]. In particular, we focused the investigation on some cellular
morpho-functional aspects, namely cell morphology, cytoskeleton assembly, proliferation, collagen
synthesis, and remodeling. The findings of the present study highlight that red PMB treatment mainly
promotes fibroblast proliferation and the cellular capability to degrade/remodel collagen, whereas
violet-blue and even more so NIR PBM, stimulate the synthetic and secretive activities of the cells
in terms of collagen expression and deposition, and likely the cell differentiation towards proto- or
myofibroblast phenotype.
2. Materials and Methods
2.1. Cell Culture
Murine NIH/3T3 fibroblasts (American Type Culture Collection, ATCC, Manassas, VA, USA) and
human dermal HDF-α fibroblasts (ScienCell, Carlsbad, CA, USA), were routinely cultured in different
plastic culture plates (6-well plate, well diameter: 30 mm; 24-well plate, well diameter: 18 mm) or on
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glass coverslips put on the bottom of a 6-well plate in proliferation medium (PM: DMEM plus 10%
fetal bovine serum (FBS) and 1% penicillin/streptomycin; Sigma, Milan, Italy). After exposure to PBM
treatments, the cells were cultured in fresh PM for further 24 h or 5 days. Cells not subjected to PBM
treatments served as controls.
2.2. PBM Treatments
PBM treatments were performed by using two diode lasers one emitting at λ = 635 ± 5 nm and
the other one (GaAlAs laser) emitting at λ = 808 ± 10 nm or by using a LED emitting at λ = 405 ± 5 nm
(Dental Laser System 4 × 4TM, General Project Ltd., Montespertoli, Florence, Italy). The three light
devices are included in a single instrument. Detailed device specifications and parameters are reported
in Table 1.
Table 1. Light device specifications.
Red Diode Laser Near Infrared (NIR)GaAlAs Diode Laser Violet-Blue LED
Wavelength (λ) 635 ± 5 nm 808 ± 10 nm 405 ± 5 nm
Handpiece type Focalized zoomhandpiece
Polymide-coated silica Fiber
NA = 0.22 Light pipe glass
Applicator Diameter 6 mm 0.6 mm 10 mm
Distance from the target 30 mm 66 mm 11 mm
The irradiation was performed in continuous wave, in non-contact mode for 30 s (single exposure
of each well containing the cells). The culture plate target diameter /surface irradiated area were
30 mm/706.9 mm2 and 18 mm/273 mm2. The power density was 12.59 mW/cm2 and the energy
density at target was 0.378 J/cm2. To avoid scattered irradiation and overlapping, cells were seeded in
separated, distant wells. Moreover, a black shield was employed to isolate each single well during
irradiation. The cells undergoing the different PBM treatments were seeded in different culture plates.
The handpieces (Figure 1) were kept at distance (see Table 1) with a delivery arm precisely positioned
above the target and perpendicular to the irradiated surface area.
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All treatments were performed under “clean bench” conditions and the temperature was monitored
and maintained belo thermal damage threshold as previously reported [34].
2.3. Cell Viability: Syto16/PI and MTS Assays
NIH/3T3 fibroblast cell viability was evaluated with two different assays. The cells were subjected
to Syto16/Propidium Iodide (PI) DNA staining test as reported previously [34]. In particular, either not
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irradiated control cells and cells subjected to PBM treatments were cultured on glass coverslips for
24 h, incubated at 37 ◦C with a Syto16 (1:2000, Molecular Probes, Eugene, OR, USA) and PI (1:100,
Molecular Probes) mix solution for 15 min and then fixed in 0.5% buffered paraformaldehyde (PFA,
Sigma) for 10 min at room temperature (RT).
The marked cells were analyzed with a confocal Leica TCS SP5 microscope (Leica Microsystems,
Mannheim, Germany). Observations and image acquisition were conducted as indicated below in the
paragraph entitled “Confocal laser scanning microscopy”.
For each cell preparation (at least three independent experiments carried out in triplicate),
the percentage of Syto16 positive viable cells was assessed in at least 10 random microscopic fields
(63× objective; 200 × 200 µm2).
The cells were also processed for MTS assay as previously reported [34]. Briefly, either not
irradiated control cells and cells subjected to PBM treatments were grown in a 24-well plate for 24 h
and then cultured in phenol-free fresh PM plus MTS test solution for 4 h. Then, the optical density (OD,
492 nm) was recorded by using a multi-well scanning spectrophotometer (ELISA reader; Amersham,
Pharmacia Biotech, Cambridge, UK).
2.4. Phase Contrast Microscopy
The morphology of NIH/3T3 fibroblasts cultured on a 6-well plate, exposed or not to PBM
treatments, was evaluated by an inverted light phase contrast microscope (Nikon Diaphot 300, Nikon,
Tokyo, Japan).
2.5. Confocal Laser Scanning Microscopy
The cells were processed for confocal immunofluorescence (IF) analysis of the expression of
different proteins essentially as previously reported [34]. Fixed cells were incubated (overnight at 4 ◦C)
with the primary antibodies listed in Table 2.
The immunoreactions were revealed by incubation (1 h at RT) with the following specific secondary
(1:200; Molecular Probes): anti-mouse Alexa Fluor 488-conjugated IgG (A11001); anti-rabbit Alexa
Fluor 488-conjugated IgG (A11034), anti-mouse Alexa 568-conjugated IgG (A11011) or anti-rabbit
Alexa 568-conjugated IgG (A11036). The cross-reactivity of the secondary antibodies was tested by
omitting primary antibodies. In some experiments, cells were labeled with Wheat Germ Agglutinin
Tetramethylrhodamine conjugate (WGA; 1:250, 15 min at RT; Thermo Fisher Scientific, Waltham, MA,
USA) to detect cellular plasma membrane, or with Alexa Fluor 488-labeled phalloidin (1:40, 20 min
at RT; Molecular Probes) to stain F-actin filaments or with PI (1:30, 10 s at RT; Molecular Probes) to
reveal nuclei.
The immunolabeled cells were observed under a confocal Leica TCS SP5 microscope (Leica
Microsystems) equipped with a HeNe/Ar laser source for fluorescence measurements and with
differential interference contrast (DIC) optics, by using a Leica Plan Apo 63×/1.43NA oil immersion
objective. Optical section series (1024 × 1024 pixels each; pixel size 204.3 nm; 0.4 µm in thickness) were
acquired at intervals of 0.6 µm and projected onto a single “extended focus” image.
Ki67 positive cell number was determined in 10 random microscopic fields (63× objective, 200 ×
200 µm2) in each cell preparation and expressed as percentage of the total cell number. Counting was
carried in at least three different cell preparations for each experimental condition by two different
operators. Experiments were performed in triplicate.
Densitometric analyses of the fluorescent signal intensity of p-FAK, vinculin, MMP-2, MMP-9,
TIMP-1, TIMP-2 and type-1 collagen were performed on digitized images using ImageJ 1.49v software
(NIH, https://imagej.nih.gov/ij/) in 20 regions of interest (ROI, 100 µm2) for each confocal stacks (at least
10). Morphometric analysis of mean cell surface area was performed on digitized DIC images taken at
the same magnification, using ImageJ 1.49v software. For each experimental group, the cell outlines of
30 cells (10 cells from 3 independent cultures) were drawn and the encircled surface area was analyzed.
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Table 2. Specifications of primary antibodies used for immunofluorescence (IF) and western blotting
(WB) analyses.








Sigma F9176 1:50 (IF)
Anti-vinculin
(mouse monoclonal, hVIN-1) Sigma V9131 1:100 (IF)
Anti-collagen 1
(rabbit polyclonal) Abcam ab34710 1:500 (IF)
Anti-α-smooth muscle actin (sma)
(mouse monoclonal, 1A4) Abcam ab7817 1:100 (IF)
Anti-MMP-2


















(mouse monoclonal, AC-74) Sigma A2228 1:10000 (WB)
2.6. Western Blotting
NIH/3T3 fibroblasts exposed or not to PBM treatments and cultured for 24 h in PM were collected
and processed to extract and detect the total proteins content by using Bio-Rad protein assay (Bio-Rad
Laboratories S.r.l., Milan, Italy). Thereafter, proteins (40 µg) were electrophoresed on NuPAGE® 4–12%
Bis-Tris Gel (Invitrogen, Life Technologies, Grand Island, NY, USA) and blotted onto polyvinylidene
difluoride (PVDF) as reported previously [34]. The membranes were incubated overnight at 4 ◦C with
the primary antibodies listed in Table 2. Immunodetection of the specific bands was performed by
using the Western Breeze®Chromogenic Immunodetection kit (Invitrogen, Life Technologies). ImageJ
1.49v software (NIH, https://imagej.nih.gov/ij/) was employed to perform the densitometric analysis of
the bands. Specific band values were normalized to β-actin (assumed as control invariant protein).
2.7. Gelatinase Assay
The MMPs’ activity in NIH/3T3 fibroblasts in the different experimental conditions was assessed
by using EnzChek® Gelatinase/Collagenase Assay Kit (Molecular Probes) as previously reported [35].
The enzymatic activity was evaluated by measuring the green fluorescence of the provided highly
quenched fluorescein-labeled gelatin (DQ™ gelatin), revealed after its digestion. In particular, the cells
were seeded on the wells of a 24-well plate, pre-coated with gelatin substrate and cultured, after exposure
or not to PBM treatments for 24 h. After that, the fluorescent intensity (515 nm) was measured by using
a multi-well scanning spectrophotometer (ELISA reader; Amersham, UK).
2.8. Statistical Analysis
Data are reported as mean ± standard error of the mean (S.E.M.) of at least three independent
experiments performed in triplicates. Student’s t test or one-way ANOVA with post-hoc Tukey HSD
were used to perform the statistical analysis of differences among the experimental groups. Results
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with a p-value < 0.05 were considered statistically significant. GraphPad Prism 9.0 statistical software
(GraphPad, San Diego, CA, USA) was used to carry out calculations.
3. Results
3.1. Effects of PBM Treatments on Fibroblast Cell Shape, Actin Cytoskeleton Assembly, Focal Adhesion Protein
Expression/Aggregation and Proliferation
Twenty-four hours after exposure to the three different PBM treatments, NIH/3T3 fibroblasts were
first assessed for cell viability by Syto16/PI and MTS assays in order to exclude any cytotoxic effect
induced by irradiations. None of the PBM treatments altered cell viability. Indeed, the irradiated cells
did not exhibit the nuclear staining of the dead cell marker PI (Figure 2A–E) and displayed values of
absorbance of soluble formazan (resulting from tetrazolium reduction by mitochondrial enzymes of
viable cells) similar to those recorded in untreated of control cells (Figure 2F).
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(635 ), IR (808 nm) and violet-blue (405 nm) PBM. Cells not subjected to PBM treatments served as
control. (A–E) Syto16/PI test. (A–D) Representative confocal fluorescence micrographs of cells stained
for Syto16 (green) and PI (red). Scale bar: 50 µm. (E,F) Histograms displaying (E) the morphometric
analysis of the percentage of Syto16 positive viable cells and (F) the absorbance of colored formazan
f rm by vi ble cells. p > 0.05.
, i i fi l i l i l i ff i i
fl l i f t ll l l it t e e ra e ye (Figure 3E– ).
Of note, morphological differences mainly in terms of cell shape and surface area may be
appreciated between the differently irradiated cells and the control ones: the NIR and violet-blue light
irradiated fibroblasts exhibited a polygonal shape and a higher surface area as compared to red light
irradiated and control ones, which appeared more elongated and spindle-shaped (Figures 3 and 4).
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Figure 3. Evaluation of the morphology and of proliferation capability of NIH/3T3 fibroblasts performed
24 h after cell exposure t red (635 nm), NIR (808 nm) and violet-blue (405 nm) PBM. Cells not subjected
to PBM treatments served as control. (A–D) Representative phase contras images of cells observ d
under an inverted phase contrast microscope. Scale bar: 20 µm. White dotted lines were depicted
to better visualize the cell shape. (E–H) Representative confocal fluorescence m crographs of fix d
cells immunostained with antibodi s ag inst the nucl a proliferation marker Ki67 (green) and stained
with T tramethylrhodamine-conjugated WGA membrane dye (red). Scal bar: 50 µm. (I) Histo ram
showing the percentage of cells with Ki67 positiv nuclei. Significance of difference: * p < 0.01 vs.
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Cytoskeleton organization and the expression of focal adhesion proteins, namely p-FAK and
vinculin, were then evaluated by confocal immunofluorescence analysis after 24 h from the PBM
treatments. NIR and violet-blue light irradiated cells exhibited an increased p-FAK expression as
compared to control ones (Figure 4A,C–E). In red light treated cells, the expression levels of p-FAK
were comparable to those of control (Figure 4A,B,E).
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Figure 4. Confocal immunofluorescence analysis of p-FAK expression in NIH/3T3 fibroblasts performed
24 h after cell exposure to red (635 nm), NIR (808 nm) and violet-blue (405 nm) PBM. Cells not subjected to
PBM treatments served as control. (A–D) Representative superimposed differential interference contrast
(DIC) and confocal fluorescence micrographs simultaneously acquired of the cells immunostained for
p-FAK (red) detection, showing the cellular localization of the protein. DIC images allow appreciating
the different morphology of the cells subjected to PBM treatments. Scale bar: 30 µm. (E) Histogram of
the densitometric analysis of p-FAK fluorescence intensity performed on digitized images. Significance
of difference: * p < 0.01 vs control (808 n , p = 0.0017; 405 nm, p = 0.0033); p = 0.89, 635 n vs. control;
p = 0.997, 405 nm vs. 808 nm. (F) Histogram showing the measure of cell surface area calculated on
digitized DIC images by using ImageJ as indicated in Materials and Methods. Significance of difference:
* p < 0.01 vs. control (808 nm, p = 0.0098; 405 nm, 0.0051); p = 0.99, 635 nm vs. control; p = 0.89, 405 nm
vs. 808 nm.
Consistent with the cell shape, the observation showed that violet-blue PBM and even more NIR
PBM, caused a robust rearrangement of the actin cytoskeletal promoting the assembly of well-organized
F-actin filaments, conceivably stress fi er-like structur s, p ralle y arranged across the cytoplasm
(Figure 5A,C,G,I,J,L) concomitant to an incre se of the expression of vi culin, mainly aggregated
in larg complexes attached to either one or both ends of the filaments, as compared to con rols
(Figure 5B,C,H,I,K,L,M).
By contrast, cells subjected o red PBM display d a reduction in t staining of F-actin filaments
which seem to be “less assembled”, as compared to control cells. Of note, these cells showed an
up-regulation of vinculin expression levels (Figure 5A–F,M).
Finally, cell proliferation analysis perform by the evaluation of the confocal immunofluorescence
xpression of the nucl ar antigen Ki67 revealed an increase of the proliferation ability of the fibroblasts
subjected to red PBM with respect to control c lls (Figure 3E,F,I). By contr st, the proliferation ability
of the fibroblasts subjected to NIR PBM appeared reduced (Figure 3E,G,I) whil violet-blue PBM did
not substantially modify th prolife ation ability of the ells as compared to control (Figure 3E,H,I).
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Figure 5. Confocal immunofluorescence analysis of F-actin cytoskeleton and focal adhesion plaque
assembly of NIH/3T3 fibroblasts performed 24 h after cell exposure to red (635 nm), NIR (808 nm) and
violet-blue (405 nm) PBM. Cells not subjected to PBM treatments served as control. (A–L) Representative
confocal fluorescence micrographs of fixed cells immunostained to detect vinculin (red) and incubated
with Alexa 488-labeled phalloidin to label F-actin (green). Scale bar: 50 µm. (M) Histogram showing the
densitometric analysis of vinculin fluorescence intensity carried out on digitized images. Significance
of difference: * p = 0.001 vs. control; # p = 0.001 vs. 635 nm; # p = 0.001 vs. 808 nm; p = 0.51, 405 nm vs.
635 nm.
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3.2. Effects of PBM Treatments on Fibroblast Type-1 Collagen and α-sma Expression
The expression of type-1 collagen was evaluated by confocal immunofluorescence analysis after
5 days from the cell PBM treatments. The observation revealed that the expression of this protein was
slightly but significantly reduced in NIH/3T3 cells exposed to red PBM (Figure 6A,B,E) whereas it
was increased in those exposed to violet-blue and even more so to NIR PBM with respect to controls
(Figure 6A,C–E). In particular, in NIR treated cells type-1 collagen expression appeared evident in the
cytoplasm with a distinctive distribution pattern, consistent with the subcellular localization of the
protein in the cisternae of elaborated endoplasmic reticulum and Golgi vesicles, suggestive of a high
cellular synthetic activity.
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Figure 6. Confocal immunofluorescence analysis of type-1 collagen expression in NIH/3T3 fibroblasts
performed 5 days after cell exposure to red (635 nm), NIR (808 nm) and violet-blue (405 nm) PBM.
Cells not subjected to PBM treatments served as control. (A–D) Representative confocal fluorescence
micrographs of fixed cells immunostained to detect type-1 collagen (green). Nuclei are labeled in
red with PI. Scale bar: 50 µm. (E) Histogram showing the densitometric analysis of type-1 collagen
fluorescence intensity performed on digitized images. Significance of difference: * p < 0.01 vs. control;
# p < 0.01 vs. 635 nm; # p < 0.01 vs. 808 nm.
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The capability of NIR PBM to affect the cell ability to synthetize type-1 collagen was also assessed
on primary human dermal fibroblasts (HDF-α). It was found that this kind of PBM elicited on
human fibroblasts similar effects as those observed on murine fibroblastic cell line. Indeed, confocal
immunofluorescence analysis revealed that the human cells after NIR PBM exposure exhibited an
increase of type-1 collagen expression at the cytoplasmic level (Figure 7A–C).
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Figure 7. Confocal immunofluorescence analysis of the expression of type-1 collagen, MMP-2
and MMP-9 in HDF-α fibroblasts 24 h (MMPs) or 5 days (type-1 collagen) after exposure to NIR
(808 nm) PBM. Cells not subjected to PBM treatments served as control. (A,B,D,E,G,H) Representative
confocal fluorescence micrographs of fixed cells immunostained for detection of (A,B) type-1 collagen,
(D,E) MMP-2 and (G,H) MMP-9 (green). Nuclei are labeled in red with PI. Scale bar: 50 µm.
(C,F,I) Histograms showing the densitometric analysis of (C) type-1 collagen, (F) MMP-2 and (I) MMP-9
fluorescence intensity performed on digitized images. Significance of difference: * p < 0.01 vs. control.
Moreover, in some irradiated cells, positive staining for type-1 collagen was observed outside the
cells in a filamentous appearance (Figure 7B), suggesting the ability of the NIR PBM to promote both
the cellular synthetic and secretive activities. Of note, in contrast to the control and red treated cells,
fibroblasts exposed to violet-blue and to NIR PBM exhibited, 24 h after the treatment, the cytoplasmic
expression of α-sma, a reliable myofibroblast marker (Figure 8), suggesting that the cells likely
underwent fibroblast-(proto)myofibroblast transition.
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Figure 8. Confocal immunofluorescence analysis of α-sma expression in NIH/3T3 fibroblasts performed
24 h after cell exposure to red (635 nm), NIR (808 nm) and violet-blue (405 nm) PBM. (A–D) Representative
confocal fluorescence micrographs of fixed cells immunostained to detect α-sma (green). Nuclei are
marked in red with PI. Scale bar: 25 µm.
3.3. Effects of PBM Treatments on Fibroblast MMP-2, MMP-9, TIMP-1 and TIMP-2 Expression and on
MMPs’ Functionality
Further experim nts were aimed at the evaluation of the expression and functionality of the
enzymes involved in the digestion of components of the ECM such as collagen, namely MMP-2
and MMP-9 gelatinases and of their specific inhibitors TIMP-1 and TIMP-2. Indeed, ECM/collagen
homeostasis and remodeling are dependent on the balanced coordination between MMPs and
TIMPs [36]. As assessed by confocal immunofluorescence and western blotting analyses, NIH/3T3
fibroblasts subjected to red PBM up-regulated either MMP-2 or MMP-9 expression (Figure 9A,B,E,F,Q
and Figure 10A,B) and concomitantly down-regulated TIMP-1 and TIMP-2 expression as compared to
control cells (Figure 9I,J,M,N,R and Figure 10C). By contrast, NIR and violet-blue PBM reduced MMP-2
and MMP-9 production (Figure 9C,D,G,H,Q and Figure 10A,B) while they enhanced the expression of
TIMP-1 and TIMP-2 (Figure 9K,L,O,P,R and Figure 10C).
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Figure 9. Confocal immunofluorescence analysis of the expression of MMP-2 and MMP-9 and of
their inhibitors, TIMP-1 and TIMP-2, in NIH/3T3 fibroblasts 24 h after cell exposure to red (635 nm),
NIR (808 nm) and violet-blue (405 nm) PBM. Cells not subjected to PBM treatments served as control.
(A–P) Representative confocal fluorescence micrographs of fixed cells immunostained for detection of
(A–D) MMP-2, (E–H) MMP-9, (I–L) TIMP-1 and (M–P) TIMP-2 (green). Nuclei are labeled in red with
PI. Scale bar: 50 µm. (Q,R) Histograms showing the densitometric analysis of (Q) MMP-2 and MMP-9
and of (R) TIMP-1 and TIMP-2 fluorescence intensity performed on digitized images. Significance of
difference in Q: * p < 0.01 vs. relative control; # p < 0.01 vs. 635 nm; p = 0.067 MMP-2, 405 nm vs.
808 nm; p = 0.06, MMP-9 405 nm vs. 808 nm. Significance of difference in R: * p < 0.01 vs. relative
control; # p < 0.01 vs. relative 635 nm, # p < 0.01 vs. relative 808 nm.
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In particular, MMP-2 resulted mainly distributed in the cytoplasm with a spotted staining
(Figure 9A–D) whereas MMP-9 was localized along the cytoskeletal filaments (Figure 9E–H).
Both TIMP-1 and TIMP-2 appeared evenly distributed within the cytoplasm (Figure 9I–P). Likewise,
murine fibroblasts, HDF-α, 24 h after NIR PBM treatment, down-regulated the expression of MMP-2
(Figure 7D–F) and MMP-9 (Figure 7G–I).
These data well correlated with the increased and reduced gelatinase activity observed in
fibroblasts after exposure to red PBM and after NIR or violet-blue PBM respectively (Figure 10D).
In fact, utilizing a fluorescent gelatin degradation test, it was found that the intensity of the fluorescent
signal augmented in the red PBM samples indicating that these treated fibroblasts were able to
synthesize functional MMPs, whereas it decreased in NIR or violet-blue PBM ones (Figure 10D).
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Figure 10. Analysis of the expression and activity of MMP-2 and MMP-9 and of the expression of
their inhibitors, TIMP-1 and TIMP-2, in NIH/3T3 fibroblasts 24 h after cell exposure to red (635 nm),
NIR (808 nm) and violet-blue (405 nm) PBM. Cells not subjected to PBM treatments served as control.
(A-C) Representative blots of western blotting analysis of (A) MMP-2 (72 KDa), (B) MMP-9 (82 KDa),
(C) TIMP-1 (26 KDa) and TIMP-2 (21 KDa). The densitometric analysis of the bands normalized to
β-actin (42 KDa) are reported in the histograms. (D) Gelatinase assay. NIH/3T3 fibroblasts were
seeded on a fluorescein-labeled gelatin substrate (DQTM gelatin). DQTM gelatin fluorescence signal
intensity (515 nm), resulting from the digestion of the gelatin by MMPs’ activity, was quantified by a
spectrophotometer. Significance of difference in A: * p < 0.01 vs. control; # p < 0.01 vs. 635 nm; p = 0.6,
405 nm vs. 808 nm. Significance of difference in B: * p < 0.01 vs. control; # p < 0.01 vs. 635 nm; p = 0.59,
405 nm vs. 808 nm. Significance of difference in C: * p < 0.01 vs. relative control; # p < 0.01 vs. relative
635 nm; # p < 0.01 vs. relative 808 nm. Significance of difference in D: * p < 0.01 vs. control; # p < 0.01
vs. 635 nm; p = 0.26, 405 nm vs. 808 nm.
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4. Discussion
In this comparative in vitro analysis, we provide compelling experimental evidence showing
the ability of fibroblastic cells to respond differently, morphologically and functionally, to three PBM
treatments performed by red, NIR, and violet-blue light centered at 635 nm, 808 nm, and 405 nm,
respectively, delivered at a constant energy density of 0.4 J/cm2.
In particular, the findings of the present study highlight that red PMB treatment mainly promotes
fibroblast proliferation and the cellular capability to degrade/remodel ECM components such as
collagen, whereas violet-blue and even more NIR PBM stimulate the synthetic and secretive activities
of the cells, in terms of collagen expression and deposition and likely the cell differentiation towards
proto- or myofibroblasts. Myofibroblasts possess the immunophenotypical and ultrastructural features
of either collagen-synthetically active fibroblasts with a prominent rough endoplasmic reticulum
or of contractile cells exhibiting de novo expression of α-sma within well assembled actin-myosin
bundles namely stress fibers and peculiar electrophysiological properties typical of smooth muscle
cells. However, with respect to fibroblasts, differentiated myofibroblasts are much larger with a more
polygonal shape and secrete higher quantity of proteoglycans, type-1 and type-3 collagen and other
components of the ECM [37–41].
In particular, our above-reported conclusions are supported by the following observations.
We have demonstrated that the percentage of fibroblasts displaying the nuclear expression of
Ki67 marker—which is expressed by the cells undergoing G1, S, G2, and mitosis cycle phases and
absent in quiescent cells during the resting G0 phase—increased after red PBM exposure. These results
agree with our previous observations in fibroblasts and other mesenchymal cells [4,34] and are in
line with studies from other groups performed on normal or wounded fibroblasts, aimed to evaluate
the proliferative cell response to red light [25,42–49]. By contrast NIR light induced a decrease of
fibroblast proliferation, whereas violet-blue light did not modify substantially the cell proliferation
rate as compared to untreated cells, according to previous reports [47,50–55].
Red PBM treated cells showed a reduced assembly of F-actin, whereas violet-blue and even more
so NIR PBM treated ones displayed well assembled and defined F-actin filaments, likely stress fibers,
together with a more polygonal shape and an increase in cell surface area, suggestive of a proto– or
myofibroblastic phenotype. These morphological features may be coherent with the proliferation
data, in line with theory stating that an increase in proliferation results in a reduction of cell size and
conversely, a decrease in proliferation produces larger cells [56]. Moreover the reduction of stress
fiber-like structures observed in red PBM treated cells may be indicative of motile migrating cells,
based on findings showing that cells with highly motility typically display few, thin and more dynamic
stress fibers and that stress fiber are not essential for cell migration [57,58]. Our results concerning the
impact of red PBM on cytoskeleton assembly properties of NIH/3T3 fibroblasts are in accordance with
a very recent paper by de Magalhães and co-workers [59]. However, differently from our findings,
these authors did not find any difference between the cell response, in terms of actin filament content,
to red and NIR light. This may be explained, in addition to the different PBM parameters applied,
by the difference in cell growth substrate rigidity, i.e., gel in the work by Magalhães et al. versus plastic
or glass in our work [59–61]. Concomitantly, cells irradiated with violet-blue and NIR light exhibited
augmented expression of focal adhesion proteins namely vinculin, which appeared mainly aggregated
at the end of stress fiber-like structures, and p-FAK which, among other functions, is required for
stress fiber formation in fibroblasts [62]. This may be an interesting finding when considering that
the formation of mature adhesion complexes associated to robust actin stress fibers results in force
transmission from myofibroblasts to the surrounding ECM, essential for the contraction and closure of
healing wounds [63].
Of note, we found that the cells exposed to red PBM also showed an up-regulation of the expression
levels of vinculin. This is not surprising when considering that, beside its structural and adhesive
role in focal adhesion contacts for cell/matrix connection, vinculin may also act as signaling protein in
cell mechanotransduction and in the modulation of several molecular signaling, involved in different
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cellular processes such as survival, growth/proliferation (e.g., ERK) and differentiation in many types
of cells, including those of mesenchymal origin [64–67].
In this study we also highlighted the capability of violet-blue and NIR light to stimulate the
secretive ability of the cells in terms of type-1 collagen synthesis, differently from red light.
Interestingly, the different collagen expression in the cells subjected to the different PBM,
well correlated with cell morphology and cytoskeleton organization we observed. Indeed, it has been
reported that fibroblasts exhibiting a reduced assembly of actin cytoskeleton and with rounded or
elongated aspect, showed a decline of type-1 collagen production [68,69].
Of interest, FAK-dependent collagen synthesis by fibroblasts has been reported, which may
contribute to further support our conclusions concerning the effect of violet-blue and NIR light in
stimulating the secretive ability of fibroblasts [70].
We also found that the cells treated with violet-blue and even more NIR PBM showed the
cytoplasmic expression of α-sma. Even if this protein does not appear organized along the stress
fiber-like structures as occurring in mature myofibroblasts, our findings further suggest the potential
acquisition of a proto-myofibroblastic phenotype after violet-blue and NIR PBM. However, the effects
of violet-blue or NIR PBM on myofibroblast differentiation and function deserve to be investigated
deeper in our cell model. By contrast, red PBM treated cells did not exhibit α-sma expression according
with previous reports showing the capability of red PBM to inhibit in vitro TGF-β1/Smad3-mediated
transition of fibroblasts towards myofibroblasts or to reduce in vivo myofibroblast population and
collagen deposition [4,71].
Finally, we found that red PBM was able to induce an increase of MMPs/TIMPs ratio and promote
MMPs’ functionality, differently from violet-blue and NIR PBM treatments that elicited an opposite
effect. Besides the role of these enzymes as secreted proteins on the ECM, involved in the maintenance
of a fine balance between ECM synthesis and degradation, essential for proper wound healing (e.g.,
necessary for favoring cell migration and provisional scar remodeling and removal), it appears worth
mentioning that a positive correlation between MMPs’ expression/function and proliferation of different
cells has been proposed [35,72,73]. Thus, the possibility that tested PBM treatments influence fibroblast
proliferation via MMPs’ modulation may not be excluded.
In this study, we only tested an energy density of 0.4 J/cm2 for red, violet-blue and NIR light
essentially to compare only the effects of different wavelengths on fibroblast responses, eliminating the
potential puzzling effect of energy density. This energy density value has been demonstrated to be an
optimal one, safe and able to exert biostimulatory effects on the cells in different experimental in vitro
conditions [4,5,34,74]. However, we are aware of the importance to test different energy densities in
our experimental system to assess and verify the occurrence of a biphasic response with a peak dose
response depicted by PBM that may account, likely together with the differences in the experimental
settings and fibroblastic cell types used, for the discrepancy of our results with those reported in the
literature [75–77]. This is a fundamental requisite to define the optimal PBM parameters able to elicit
the best fibroblast responses with therapeutic effects and to appropriately translate this information
into clinical protocols.
A limitation of this study mainly correlates to the in vitro experimentation on cell monolayers.
If on the one side, this basic model represents a very relevant tool for studying the impact of light
on the cells in a simple and reproducible way, on the other side it eliminates may relevant factors
including: i) the complex architecture of a tissue affecting light propagation; ii) many mechanisms
possibly regulating in vivo paracrine/juxtacrine cell–cell interactions and cell functionality; iii) the
microenvironmental mechanical forces such as ECM stiffness, known to affect cell behavior by
instructive signals [78–80]. Hence, the translation of the findings obtained in vitro to in vivo situations
must be, as always, considered with caution. However, this study may provide experimental
groundwork to push clinicians towards the use of multiple combined photo-treatments for addressing
wound healing [12,14,81]. It is tempting to speculate that red PBM treatment in combination with
violet-blue or NIR PBM, if properly conducted respecting the sequence of events through which wound
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healing proceeds [82], could really elicit positive biological effects and provide better results than
those achieved by the single treatments for the promotion and improvement of the healing process,
thus holding a promising therapeutic potential. In particular red PBM may favor the proliferative stage
of wound healing stimulating the essential cellular elements such as fibroblasts [32] from the wound
margin to proliferate and migrate into the wound starting to form ECM (initially containing immature
type-3 collagen), while modulating the first inflammatory response as reported [83–85]. On the other
hand, PBM mediated by violet-blue or even more NIR light may promote the late matrix remodeling
(maturation) stage of wound healing, likely stimulating the differentiation of fibroblasts towards
myofibroblasts and the production and deposition of mature type-1 collagen by (myo)fibroblasts,
thus leading to the formation of a transient contractile scar, which reduces the wound size and allows
its final closure, in an attempt to rapidly restore tissue integrity. Experiments are ongoing in our lab to
further investigate the proliferative, migratory, and secretive responses of fibroblastic cells to different
PBM treatments in wound models to corroborate our hypothesis.
Finally, it is also worth saying that, from a clinical perspective, multi-photonic supportive treatment
to wound healing appears to be a feasible therapeutic option. Being encompassed within the so-called
low-energy phototherapies, it can be effectively performed by means of LED emitters, whose major
advantages are the possibility to assemble different light sources at appropriate wavelengths in a single
instrument, ease of use and low costs. On the other hand, photonic therapies usually require repeated
applications until achievement of the therapeutic goals. To this end, the development of portable
multi-LED instruments may be desirable. Such devices would allow for the delivery of efficacious
photonic wound treatment protocols at the patients’ home under medical supervision.
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